Skip to content
OpenCapital
Get started

Sanara MedTech Inc. SMTI Indefinite-Lived Research and Development Assets

Indefinite-Lived Research and Development Assets at other companies

HTF
Heartflow, Inc. Common StockHTFL
$15.41M-25.5%
Photronics logo
PhotronicsPLAB
$3.9M+43.5%
Starfighters Space, Inc. logo
Starfighters Space, Inc. FJET
$244.99K—
XTI Aerospace, Inc. logo
XTI Aerospace, Inc.XTIA
$756K-37.7%
Aptera Motors Corp. logo
Aptera Motors Corp. SEV
$10.84M-13.7%
NTH
NeOnc Technologies Holdings, Inc. Common StockNTHI
$1.23M—

Other financials

Income statement

See full
Revenue$27.8M+18.6%
Gross profit$25.9M+19.8%
Operating income$2.6M+221%
Net income$459.0K+113%
EPS (diluted)$0.05+112%

Balance sheet

See full
Cash & equivalents$13.6M-34.3%
Total debt$48.4M+8.2%
Total equity$7.0M-80.8%
Total assets$69.3M-28.1%

Cash flow

See full
Operating cash flow-$2.5M-23.3%
CapEx$43.8K-97.5%
Free cash flow-$2.5M+32.6%

Valuation

See full
Market cap$216.18M-9.7%
Enterprise value$250.95M-6.5%
P/S2×-0.5×

Profitability

See full
Gross margin92.9%+1.8pp
Operating margin6.1%+5.1pp
Net margin-31.2%-93.4pp
FCF margin-9.8%-3.5pp

Returns & leverage

See full
Return on equity-153.7%-199pp
Debt / equity6.9×+5.7×
Current ratio2.3×-0.5×

Where this comes from

Reported directly by Sanara MedTech Inc. in its filing.

Tagged under the XBRL concept us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment.

The official record: Sanara MedTech Inc.’s 10-K, filed March 24, 2026, on SEC EDGAR. View the filing →

Ask your AI about Sanara MedTech Inc.'s indefinite-lived research and development assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Sanara MedTech Inc.'s indefinite-lived research and development assets?
Sanara MedTech Inc. (SMTI) reported indefinite-lived research and development assets of $2.21M in Q4 2025.
What is the long-term trend for Sanara MedTech Inc.'s indefinite-lived research and development assets?
Over 3 years (2022 to 2025), Sanara MedTech Inc.'s indefinite-lived research and development assets has grown at a 46.3% compound annual growth rate (CAGR), from $707.08K to $2.21M.
What does indefinite-lived research and development assets mean?
These are acquired in-process research and development assets that are not currently amortized because their useful life is indeterminate until the project reaches completion or is abandoned. This balance reflects the company's investment in future innovation and pipeline growth. Changes in this value indicate progress in R&D milestones or potential impairment risks.